Malin Corporation | MLC - Eigenkapital Und Reserven





Eigenkapital Und Reserven Veränderung Datum
Akebia Therapeutics USD 25.02M 2.36M 2026-06
Alaunos Therapeutics USD 1.29M 865K 2026-03
ALKERMES USD 1.81B 57.02M 2026-06
Avita Medical AUD -16.65M 3.76M 2025-12
Dianthus Therapeutics USD 1.17B 29.29M 2026-06
Eurofins Scientific SE EUR 3.62B 76M 2026-06
Ionis Pharmaceuticals USD 439.74M 51.68M 2026-06
IQVIA Holdings USD 6.17B 50M 2026-06
Lonza CHF 9.13B 513M 2025-12
Malin Corporation EUR 193.2M 75M 2024-12
Moderna USD 6.76B 647M 2026-06
Organon & Co USD 1.01B 103M 2026-06
Ovoca Bio EUR 780K 485K 2025-12
Revvity USD 7.18B 67.62M 2026-03
Tectonic Therapeutic USD 230.42M 20.91M 2026-03
Viatris USD 14.26B 397.3M 2026-06
Xeris Pharmaceuticals USD -9.73M 22.74M 2026-06